Adagio Medical is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Adagio Medical is a company founded in 2012 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.